Literature DB >> 29678064

Engaging Stakeholders in the Design and Usability Evaluation of a Decision Aid to Improve Secondary Stroke Prevention.

Talya Porat1, Zhining Liao1, Vasa Curcin1.   

Abstract

Stroke survivors have a nearly 40% risk of recurrent stroke during the first 10 years. Effective secondary stroke prevention strategies are sub-optimally used, and hence, developing interventions to enable healthcare professionals and stroke survivors to manage risk factors more effectively are required. In this paper we describe the usability evaluation of a decision aid designed in collaboration with stakeholders to reduce the risk of a recurrent stroke. The decision aid was found usable and acceptable by both general practitioners and stroke survivors. Concerns and suggestions for improving the decision aid are discussed.

Entities:  

Keywords:  Stroke; decision aid; decision support system; learning health system; usability testing

Mesh:

Year:  2018        PMID: 29678064

Source DB:  PubMed          Journal:  Stud Health Technol Inform        ISSN: 0926-9630


  3 in total

1.  Collaborative design of a decision aid for stroke survivors with multimorbidity: a qualitative study in the UK engaging key stakeholders.

Authors:  Talya Porat; Iain J Marshall; Euan Sadler; Miguel A Vadillo; Christopher McKevitt; Charles D A Wolfe; Vasa Curcin
Journal:  BMJ Open       Date:  2019-08-15       Impact factor: 2.692

2.  How do electronic risk assessment tools affect the communication and understanding of diagnostic uncertainty in the primary care consultation? A systematic review and thematic synthesis.

Authors:  Alex Burns; Brian Donnelly; Joshua Feyi-Waboso; Elizabeth Shephard; Raff Calitri; Mark Tarrant; Sarah Gerard Dean
Journal:  BMJ Open       Date:  2022-06-29       Impact factor: 3.006

3.  Public Health and Risk Communication During COVID-19-Enhancing Psychological Needs to Promote Sustainable Behavior Change.

Authors:  Talya Porat; Rune Nyrup; Rafael A Calvo; Priya Paudyal; Elizabeth Ford
Journal:  Front Public Health       Date:  2020-10-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.